Modulation of Thrombospondin 1 and Pigment Epithelium–Derived Factor Levels in Vitreous Fluid of Patients With Diabetes
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the levels of 2 endogenous inhibitors of angiogenesis, thrombospondin 1 (TSP-1) and pigment epithelium-derived factor (PEDF), in the vitreous fluid from patients with and without diabetes. METHODS: The levels of TSP-1 and PEDF in vitreous samples from diabetic and age-matched nondiabetic patients were determined by Western blot analysis. RESULTS: We observed significant amounts of TSP-1 and PEDF in the vitreous samples of control eyes. The TSP-1 levels varied in samples from patients with diabetes. In contrast, PEDF levels showed little or no change in vitreous samples from patients with or without diabetes. However, the PEDF protein exhibited variation in its molecular weight among the samples. We consistently observed lower levels of TSP-1 in diabetic patients who expressed the higher-molecular-weight PEDF isoform. CONCLUSIONS: In diabetes, changes in the TSP-1 level may play a role in shifting the angiogenic balance and contributing to the pathogenesis of diabetic retinopathy. Although the PEDF level did not change, the diabetic samples with the higher-molecular-weight PEDF isoform consistently showed lower levels of TSP-1. CLINICAL RELEVANCE: The presence of the higher-molecular-weight PEDF isoform may be associated with greater risk of severe diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis
Christopherson, K. S., Ullian, E. M., Stokes, C. C. A., Mullowney, C. E., Hell, J. W., Agah, A., Lawler, J., Mosher, D. F., Bornstein, P., & Barres, B. A. (2005) · Cell · doi:10.1016/j.cell.2004.12.020 · Cited by 1,688 · cited 1×
“Production of TSP-1 and TSP-2 by astrocytes has recently been shown to be essential for appropriate synaptogenesis and retinal neuronal functions.(42) Thus, alterations in TSP-1 levels may also affect retinal neuronal functions, contributing to visual dysfunctions associated with diabetes.”
Bhutto, I. A., McLeod, D. S., Hasegawa, T., Kim, S. Y., Merges, C., Tong, P., & Lutty, G. A. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.05.007 · Cited by 275 · cited 2×
“There are also reports that the PEDF concentration was higher in the vitreous from patients with diabetes.(22,23) Our study showed that PEDF was at consistently high levels in the eyes of diabetic patients and control subjects.”
Wang, S., Wu, Z., Sorenson, C. M., Lawler, J., & Sheibani, N. (2003) · Developmental Dynamics · doi:10.1002/dvdy.10412 · Cited by 133 · cited 4×
“Endogenous inhibitors of angiogenesis, including thrombospondin 1 (TSP-1) and pigment epithelium–derived factor (PEDF), which are present at ocular avascular sites such as vitreous, may play a key role in retinal vascular homeostasis.(4,5) Thrombospondin 1 is a member of the thrombospondin family of the matricellular…”
InfluentialSelf-citationSheibani, N., Sorenson, C. M., Cornelius, L. A., & Frazier, W. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1903 · Cited by 109 · cited 7×
“We consider TSP-1 to be an angiogenesis inhibitor associated with the development and progression of diabetic retinopathy.(8) Thrombospondin 1 is present in vitreous and aqueous humor at high levels and is produced by almost all known cell types in the eye, including retinal ECs, astrocytes, and pericytes, and elsewhe…”
InfluentialEnhanced proangiogenic signaling in thrombospondin-1-deficient retinal endothelial cells
Wang, Y., Wang, S., & Sheibani, N. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.02.004 · Cited by 34
Self-citation
Cited by
Role of Inflammation in Diabetic Retinopathy
Rübsam, A., Parikh, S., & Fort, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040942 · Cited by 750
Lack of thrombospondin 1 and exacerbation of choroidal neovascularization
Wang, S., Sorenson, C. M., & Sheibani, N. (2012) · Archives of Ophthalmology · doi:10.1001/archopthalmol.2011.1892 · Cited by 61
Self-citationMasli, S., Sheibani, N., Cursiefen, C., & Zieske, J. (2014) · Current Eye Research · doi:10.3109/02713683.2013.877936 · Cited by 54
“We and others have shown that PEDF is also present in vitreous samples prepared from humans with and without diabetes.(52) The physiological roles of these molecules in retinal vascular development and pathogenesis of various ocular diseases remains an area of significant importance for investigation.”
BackgroundResultThrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy
Shoujian Wang, C. M. S., & Nader Sheibani, R. G. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s12-005 · Cited by 44
“We have recently shown that the level of PEDF is minimally affected in vitreous samples from diabetic patients [5].”
BackgroundResultInfluential
Metadata
- Authors
- Wang, S.
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2009-04-13
- Volume
- 127
- Issue
- 4
- Pages
- 507
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W1991757995
- Cited by
- 50
- References
- 5
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modulation of Thrombospondin 1 and Pigment Epithelium–Derived Factor Levels in Vitreous Fluid of Patients With Diabetes. https://app.cochat.ai/papers/10.1001/archophthalmol.2009.53
- The paper
- Wang, S. (2009). Modulation of Thrombospondin 1 and Pigment Epithelium–Derived Factor Levels in Vitreous Fluid of Patients With Diabetes. Archives of Ophthalmology. https://doi.org/10.1001/archophthalmol.2009.53
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.